Реферат: Магний при патологии беременности и родов
34. Hamersley S.L., Landy H.J., O’Sullivan M.J. Fetal bradycardia secondary to magnesium sulfate therapy for preterm labor. A case report. Reprod Med 1998; 43 (3): 206–210
35. Hennessy A., Hill I. A case of maternal bradycardia at therapeutic doses of magnesium sulphate in preeclampsia. Aust N Z J Obstet Gynaecol 1999; 39 (2): 256–257
36. Herschel M., Mittendorf R.J. Tocolytic magnesium sulfate toxicity and unexpected neonatal death. Perinatol 2001; 21 (4): 261–262
37. Jacob S., Gopalakrishnan K., Lalitha K. Standartised clinical trial of magnesium sulphate regime in comparison with M.K.K. Menon’s lytic coctail regime in the management of eclampsia. Proceedings of the 27th British Congress of Obstetrics and Gynaecology; 4–7 July 1995; Dublin, 1995: 303
38. Jaspers V., Spatling L., Fallenstein F., Quakernack K. Magnesium, calzium, hamoglobin, hamatokrit, ostriol und HPL unter magnesiumsubstitution in der schwangerschaft. Geburtshilfe–Frauenheilkd 1990; 50: 628–633
39. Kamitomo M., Sameshima H., Ikenoue T., Nishibatake M.J. Fetal cardiovascular function during prolonged magnesium sulfate tocolysis. Perinat Med 2000; 28 (5): 377–382
40. Kantas E., Cetin A., Kaya T., Cetin M. Effect of magnesium sulfate, isradipine, and ritodrine on contractions of myometrium: pregnant human and rat. Acta Obstet Gynecol Scand 2002; 81 (9): 825–830
41. Katz V.L., Farmer R.M. Controversies in tocolytic therapy. Clin Obstet Gynecol 1999; 42 (4): 802–819
42. Kisters K., Barenbrock M., Louwen F. et al. Membrane, intracellular, and plasma magnesium and calcium concentrations in preeclampsia Am J Hypertens 2000; 13 (7): 765–769
43. Kovacs L.M., Molnar B.G., Huhn E., Bodis L. Magnesiumsubstitution in der Schwangerschaft: eine prospektiye, randomisierte doppelblindstudie. Geburtsh u Frauenheilk 1988; 48: 595–600
44. Kuno N., Ishikawa K Serum creatine phosphokinase elevation in patients treated with intravenous magnesium sulfate. Int J Gynaecol Obstet 2002; 76 (3): 257–266
45. Lemancewicz A., Laudanska H., Laudanski T. et al. Permeability of fetal membranes to calcium and magnesium: possible role in preterm labour. Hum Reprod 2000; 15 (9): 2018–2222
46. Li S., Tian H. Oral low–dose magnesium gluconate preventing pregnancy induced hypertension. Zhonghua Fu Chan Ke Za Zhi 1997; 32 (10): 613–615
47. Lu J.F., Nightingale C.H. Magnesium sulfate in eclampsia and pre–eclampsia: pharmacokinetic principles. Clin Pharmacokinet 2000; 38 (4): 305–314
48. Lurie S., Rotmensch S., Feldman N., Glezerman M. Breast engorgement and galactorrhea during magnesium sulfate treatment of preterm labor. Am J Perinatol 2002; 19 (5): 239–240
49. Macones G.A., Sehdev H.M., Berlin M. et al. Evidence for magnesium sulfate as a tocolytic agent. Obstet Gynecol Surv 1997; 52 (10): 652–658
50. The Magpie Trial Collaboration Group. Do women with pre–eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo–controlled trial. Lancet 2002; 359 (9321): 1877–1890
51. Manyemba J. Magnesium sulphate for eclampsia: putting the evidence into clinical practice. Cent Afr J Med 2000; 46 (6): 166–169
52. Matsuda Y., Kouno S., Hiroyama Y. et al. Intrauterine infection, magnesium sulfate exposure and cerebral palsy in infants born between 26 and 30 weeks of gestation. Eur J Obstet Gynecol Reprod Biol 2000; 91 (2): 159–164
53. Mittendorf R., Pryde P.G. An overview of the possible relationship between antenatal pharmacologic magnesium and cerebral palsy. Med J Perinat 2000; 28 (4): 286–293
54. Mittendorf R., Dambrosia J., Pryde P.G. et al. Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. Am J Obstet Gynecol 2002; 186 (6): 1111–1118
55. Mittendorf R., Dambrosia J., Dammann O.J. et al. Association between maternal serum ionized magnesium levels at delivery and neonatal intraventricular hemorrhage. Pediatr 2002; 140 (5): 540–546
56. Morisaki H., Yamamoto S., Morita Y. J. et al. Hypermagnesemia–induced cardiopulmonary arrest before induction of anesthesia for emergency cesarean section. Clin Anesth 2000; 12 (3): 224–226
57. Morgan P.J., Kung R., Tarshis J. Nitroglycerin as a uterine relaxant: a systematic review. J Obstet Gynaecol Can 2002; 24 (5): 403–409
58. Morrison E.H. Common peripartum emergencies. Am Fam Physician 1998; 58 (7): 1593–1604
59. Naidu S., Payne A.J., Moodley J. Randomised study assessing the effect of phenytoin and magnesium sulphate on maternal cerebral circulation in eclampsia using transcranial Doppler ultrasound. Br. J. Obstet. Gynaecol. 1996; 103: 111–116
60. Ohta N., Tsukahara H., Yamashita N. et al. Infantile renal dysfunction associated with intrauterine exposure to ritodrine and magnesium sulfate. Nephron 2002; 91 (2): 352–353
61. Phillippe M. Cellular mechanisms underlying magnesium sulfate inhibition of phasic myometrial contractions. Biochem Biophys Res Commun 1998; 252 (2): 502–507
62. Pryde P.G., Besinger R.E., Gianopoulos J.G., Mittendorf R. Adverse and beneficial effects of tocolytic therapy. Semin Perinatol 2001; 25 (5): 316–340